• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » New brain technology for ALS patients will launch clinical trials in Philadelphia

New brain technology for ALS patients will launch clinical trials in Philadelphia

October 21, 2013
CenterWatch Staff

A new technology that will enable patients suffering from ALS—commonly known as Lou Gehrig's disease—to communicate via brain monitor, will hold its first clinical trials in Philadelphia. Congressman Chaka Fattah (PA-02) was on hand for the announcement, made Tuesday at the BrainTech Israel conference in Tel Aviv.

The announcement came days after Fattah and Dr. Philip Low, who patented the device, met in Fattah's Capitol Hill office to discuss future opportunities to partner around neuroscience, and encourage investment in brain technology in the U.S.

Low, founder and CEO of NeuroVigil, a San Diego-based company, have filed a patent for the new brain monitor—the world's smallest yet. Low has presented early evidence of the brain monitor's success to the nearly 700 assembled investors, scientists, researchers and patients. Conference attendees watched on video as an ALS patient (the first ever to do so) spelled his first word without using his body, by using non-invasive, single-channel, mind-enabled communication. Low has developed other technologies using the monitor to test on patients in various stages of ALS.

In the U.S., approximately 5,600 individuals are diagnosed with ALS each year. Some estimate that as many as 30,000 Americans may have the disease at any given time.

"We are starting an entire ALS center at NASA to work with people who have pathologies. We are going to continue the clinical trial in Philadelphia. We are delighted to work with Congressman Fattah and the president [Obama] on the BRAIN initiative," said Low. "And we're working to create a neurotechnology cluster that will enable us to work together—whether we're in the U.S. or Israel, or anywhere else in the world."

The satellite research laboratory will operate from NASA's Research Park in Mountain View, Calif., and will allow Low to continue developing the assistive technologies before starting trials for the new technology. Low, who created the iBrain—a portable neural device that monitors and diagnoses brain conditions—previously held clinical trials for his research at Drexel University in Philadelphia.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing